Professor of Translational Research
Leader of CIT and CTCC
Our team offers expertise in all types of clinical research studies and advances current tools e.g. to preventative and therapeutic adaptive platform trials. We match research questions with tailored study design and built suitable networks of clinical study sites in currently 95 countries.
Our research focuses on clinical trial design. Designs range from non-interventional registries and cohorts to interventional studies comparing a new approach with current standard. Cutting edge technologies we offer comprise fully adaptive platform trials in prevention and prophylaxis. We run studies in patients and in healthy volunteers. Our most active Volunteer Registry comprises 37.000 people in Germany, 90% adults, 10% children. Our site networks cover 95 countries in all UN regions, where we collaborate with about 1100 scientists.
Settings in focus range from infections as they peak at the extremes of age, to acquired and inherited immunocompromise states and associated diseases, to metabolism research, to vaccine preventable diseases.
We counsel on any health or disease study topic CECAD investigators address.
Where lab and clinics closely interact, ideas and solutions of practical value are propelled. Our tailored study designs pave the way to patients and healthy volunteers without delay.
Professor of Translational Research
Leader of CIT and CTCC